163 related articles for article (PubMed ID: 31802366)
1. Biodistribution and pharmacokinetic profiles of an altered peptide ligand derived from heat-shock proteins 60 in Lewis rats.
Del Carmen Domínguez M; Cabrales A; Lorenzo N; Padrón G; Gonzalez LJ
Cell Stress Chaperones; 2020 Jan; 25(1):133-140. PubMed ID: 31802366
[TBL] [Abstract][Full Text] [Related]
2. CIGB-814, an altered peptide ligand derived from human heat-shock protein 60, decreases anti-cyclic citrullinated peptides antibodies in patients with rheumatoid arthritis.
Corrales O; Hernández L; Prada D; Gómez J; Reyes Y; López AM; González LJ; Del Carmen Domínguez Horta M
Clin Rheumatol; 2019 Mar; 38(3):955-960. PubMed ID: 30415439
[TBL] [Abstract][Full Text] [Related]
3. An altered peptide ligand corresponding to a novel epitope from heat-shock protein 60 induces regulatory T cells and suppresses pathogenic response in an animal model of adjuvant-induced arthritis.
Dominguez Mdel C; Lorenzo N; Barbera A; Darrasse-Jeze G; Hernández MV; Torres A; Hernández I; Gil R; Klatzmann D; Padrón G
Autoimmunity; 2011 Sep; 44(6):471-82. PubMed ID: 21370936
[TBL] [Abstract][Full Text] [Related]
4. APL-1, an altered peptide ligand derived from human heat-shock protein 60, selectively induces apoptosis in activated CD4+ CD25+ T cells from peripheral blood of rheumatoid arthritis patients.
Barberá A; Lorenzo N; Garrido G; Mazola Y; Falcón V; Torres AM; Hernández MI; Hernández MV; Margry B; de Groot AM; van Roon J; van der Zee R; Broere F; van Eden W; Padrón G; Domínguez Mdel C
Int Immunopharmacol; 2013 Dec; 17(4):1075-83. PubMed ID: 24177275
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic effect of an altered peptide ligand derived from heat-shock protein 60 by suppressing of inflammatory cytokines secretion in two animal models of rheumatoid arthritis.
Lorenzo N; Barberá A; Domínguez MC; Torres AM; Hernandez MV; Hernandez I; Gil R; Ancizar J; Garay H; Reyes O; Altruda F; Silengo L; Padrón G
Autoimmunity; 2012 Sep; 45(6):449-59. PubMed ID: 22686732
[TBL] [Abstract][Full Text] [Related]
6. CIGB-258, a peptide derived from human heat-shock protein 60, decreases hyperinflammation in COVID-19 patients.
Hernandez-Cedeño M; Venegas-Rodriguez R; Peña-Ruiz R; Bequet-Romero M; Santana-Sanchez R; Penton-Arias E; Martinez-Donato G; Guillén-Nieto G; Dominguez-Horta MDC
Cell Stress Chaperones; 2021 May; 26(3):515-525. PubMed ID: 33629254
[TBL] [Abstract][Full Text] [Related]
7. APL1, an altered peptide ligand derived from human heat-shock protein 60, increases the frequency of Tregs and its suppressive capacity against antigen responding effector CD4 + T cells from rheumatoid arthritis patients.
Barberá A; Lorenzo N; van Kooten P; van Roon J; de Jager W; Prada D; Gómez J; Padrón G; van Eden W; Broere F; Del Carmen Domínguez M
Cell Stress Chaperones; 2016 Jul; 21(4):735-44. PubMed ID: 27241313
[TBL] [Abstract][Full Text] [Related]
8. APL-1, an altered peptide ligand derived from heat-shock protein, alone or combined with methotrexate attenuates murine collagen-induced arthritis.
Lorenzo N; Altruda F; Silengo L; Del Carmen Dominguez M
Clin Exp Med; 2017 May; 17(2):209-216. PubMed ID: 27160252
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of adjuvant-induced arthritis by interleukin-10-driven regulatory cells induced via nasal administration of a peptide analog of an arthritis-related heat-shock protein 60 T cell epitope.
Prakken BJ; Roord S; van Kooten PJ; Wagenaar JP; van Eden W; Albani S; Wauben MH
Arthritis Rheum; 2002 Jul; 46(7):1937-46. PubMed ID: 12124879
[TBL] [Abstract][Full Text] [Related]
10. A peptide derived from HSP60 reduces proinflammatory cytokines and soluble mediators: a therapeutic approach to inflammation.
Domínguez-Horta MDC; Serrano-Díaz A; Hernández-Cedeño M; Martínez-Donato G; Guillén-Nieto G
Front Immunol; 2023; 14():1162739. PubMed ID: 37187739
[TBL] [Abstract][Full Text] [Related]
11. The T cells specific for the carboxyl-terminal determinants of self (rat) heat-shock protein 65 escape tolerance induction and are involved in regulation of autoimmune arthritis.
Durai M; Gupta RS; Moudgil KD
J Immunol; 2004 Mar; 172(5):2795-802. PubMed ID: 14978079
[TBL] [Abstract][Full Text] [Related]
12. HSP60 as a target of anti-ergotypic regulatory T cells.
Quintana FJ; Mimran A; Carmi P; Mor F; Cohen IR
PLoS One; 2008; 3(12):e4026. PubMed ID: 19107191
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a bioanalytical method based on LC-MS/MS analysis for the quantitation of CIGB-814 peptide in plasma from Rheumatoid Arthritis patients.
Cabrales-Rico A; Ramos Y; Besada V; Del Carmen Domínguez M; Lorenzo N; García O; Alexis J; Prada D; Reyes Y; López AM; Masforrol Y; Garay H; González LJ
J Pharm Biomed Anal; 2017 Sep; 143():130-140. PubMed ID: 28595106
[TBL] [Abstract][Full Text] [Related]
14. Bystander suppression of experimental arthritis by nasal administration of a heat shock protein peptide.
Zonneveld-Huijssoon E; Roord ST; de Jager W; Klein M; Albani S; Anderton SM; Kuis W; van Wijk F; Prakken BJ
Ann Rheum Dis; 2011 Dec; 70(12):2199-206. PubMed ID: 21914624
[TBL] [Abstract][Full Text] [Related]
15. DNA fragments of the human 60-kDa heat shock protein (HSP60) vaccinate against adjuvant arthritis: identification of a regulatory HSP60 peptide.
Quintana FJ; Carmi P; Mor F; Cohen IR
J Immunol; 2003 Oct; 171(7):3533-41. PubMed ID: 14500649
[TBL] [Abstract][Full Text] [Related]
16. Heat shock protein 65-reactive T cells are involved in the pathogenesis of non-antigenic dimethyl dioctadecyl ammonium bromide-induced arthritis.
Mia MY; Durai M; Kim HR; Moudgil KD
J Immunol; 2005 Jul; 175(1):219-27. PubMed ID: 15972652
[TBL] [Abstract][Full Text] [Related]
17. Peptide-induced nasal tolerance for a mycobacterial heat shock protein 60 T cell epitope in rats suppresses both adjuvant arthritis and nonmicrobially induced experimental arthritis.
Prakken BJ; van der Zee R; Anderton SM; van Kooten PJ; Kuis W; van Eden W
Proc Natl Acad Sci U S A; 1997 Apr; 94(7):3284-9. PubMed ID: 9096385
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of adjuvant-induced arthritis by DNA vaccination with the 70-kd or the 90-kd human heat-shock protein: immune cross-regulation with the 60-kd heat-shock protein.
Quintana FJ; Carmi P; Mor F; Cohen IR
Arthritis Rheum; 2004 Nov; 50(11):3712-20. PubMed ID: 15529360
[TBL] [Abstract][Full Text] [Related]
19. Targeting of tolerogenic dendritic cells to heat-shock proteins in inflammatory arthritis.
Spiering R; Jansen MAA; Wood MJ; Fath AA; Eltherington O; Anderson AE; Pratt AG; van Eden W; Isaacs JD; Broere F; Hilkens CMU
J Transl Med; 2019 Nov; 17(1):375. PubMed ID: 31727095
[TBL] [Abstract][Full Text] [Related]
20. Experimental immunization with anti-rheumatic bacterial extract OM-89 induces T cell responses to heat shock protein (hsp)60 and hsp70; modulation of peripheral immunological tolerance as its possible mode of action in the treatment of rheumatoid arthritis (RA).
Bloemendal A; Van der Zee R; Rutten VP; van Kooten PJ; Farine JC; van Eden W
Clin Exp Immunol; 1997 Oct; 110(1):72-8. PubMed ID: 9353151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
